Literature DB >> 6404045

An immunological study of germinal centres in four ophthalmic immunocytomas.

W M Molenaar, E W Schwarze, K Lennert.   

Abstract

Four ophthalmic lymphoplasmacytic/lymphoplasmacytoid (LP) immunocytomas with germinal centres were reviewed histologically and studied immunologically by means of the peroxidase-antiperoxidase (PAP) method. In two cases a histological diagnosis of LP immunocytoma was made, while in the other two cases a non-Hodgkin's lymphoma could not be histologically differentiated with certainty from a pseudolymphoma or reactive process. Immunological analysis confirmed the diagnosis in the former two cases and led in one of the latter also to a diagnosis of LP immunocytoma. In the fourth case the development of LP immunocytoma out of a pseudolymphoma could be demonstrated. In the four LP immunocytomas the germinal centres showed a monoclonal pattern of immunoglobulin in one case, a polyclonal pattern in one case and a negative reaction in two cases. The role of germinal centres in relation to the development of LP immunocytoma is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404045     DOI: 10.1007/BF00619575

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  13 in total

1.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

2.  Orbital lymphomas and pseudolymphomas: a clinicopathologic study of eleven cases.

Authors:  A G Kelly; A Rosas-Uribe; S T Kraus
Journal:  Am J Clin Pathol       Date:  1977-09       Impact factor: 2.493

3.  [Primary malignant lymphoid tumors of the eye, the orbit and its attachments: prognosis and results according to histologic types].

Authors:  C Haye; R Calle; M A Dollfus; A Zadjela; P Schlienger
Journal:  Ann Ocul (Paris)       Date:  1968-09

4.  Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome).

Authors:  U Schmid; D Helbron; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 5.  Pathology of 'pseudotumours' of the orbit: a review.

Authors:  A Garner
Journal:  J Clin Pathol       Date:  1973-09       Impact factor: 3.411

6.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

7.  Immunoglobulin-containing plasma cells in chronic parotitis and malignant lymphomas of the parotid gland. Comparing immunocytochemical observations of frequency and localization.

Authors:  C von Gumberz; G Seifert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  [Malignant and benign lymphomas of the eye, eyelid, and orbit (author's transl)].

Authors:  E W Schwarze; T Radaszkiewicz; G Pülhorn; M Goos; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-04-05

9.  Immunologic characterization of ocular adnexal lymphoid neoplasms.

Authors:  D M Knowles; F A Jakobiec; J P Halper
Journal:  Am J Ophthalmol       Date:  1979-05       Impact factor: 5.258

10.  Differential diagnosis in Mikulicz's syndrome, Mikulicz's disease, and similar disease entities.

Authors:  D Meyer; M Yanoff; H Hanno
Journal:  Am J Ophthalmol       Date:  1971-02       Impact factor: 5.258

View more
  3 in total

1.  Immunocytoma of the skin simulating lymphadenosis benigna cutis.

Authors:  S C van der Putte; J Toonstra; H J Schuurman; J A van Unnik
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Follicular malignant non-Hodgkin's lymphoma with pronounced plasmacytic differentiation: a plasmacytoma-like lymphoma.

Authors:  U Schmid; J Karow; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Uveal lymphoid infiltrates: immunohistochemical evidence for a lymphoid neoplasia.

Authors:  D Ben-Ezra; J A Sahel; N L Harris; I Hemo; D M Albert
Journal:  Br J Ophthalmol       Date:  1989-10       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.